2018
DOI: 10.1038/s41388-018-0283-3
|View full text |Cite
|
Sign up to set email alerts
|

Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12

Abstract: The TP53-MDM2-AR-AKT signalling network plays a critical role in the development and progression of prostate cancer. However, the molecular mechanisms regulating this signalling network are not completely defined. By conducting transcriptome analysis, denaturing immunoprecipitations and immunopathology, we demonstrate that the TP53-MDM2-AR-AKT cross-talk is regulated by the deubiquitinating enzyme USP12 in prostate cancer. Our findings explain why USP12 is one of the 12 most commonly overexpressed cancer-assoc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
30
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 34 publications
(31 citation statements)
references
References 50 publications
0
30
0
Order By: Relevance
“…ARHGEF7 plays a role in cytoskeleton remodeling, and may regulate cancer cell motility [ 35 ], USF1 expression is related to cellular stress and senescence, immune response and carcinogenesis and has been shown to be associated with shorter life expectancy [ 36 ]. USP12 is a deubiquitinating enzyme that plays a critical role in TP53 tumor suppressor levels [ 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…ARHGEF7 plays a role in cytoskeleton remodeling, and may regulate cancer cell motility [ 35 ], USF1 expression is related to cellular stress and senescence, immune response and carcinogenesis and has been shown to be associated with shorter life expectancy [ 36 ]. USP12 is a deubiquitinating enzyme that plays a critical role in TP53 tumor suppressor levels [ 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…In PCa, fundamental components of the SE complexes, such as BDR4 and ERG, densely bind to the enhancer and SE elements to promote tumorigenesis and tumor growth. In advanced CRPC patients, the SE activity created by these transcription factors remains stable and evolves to be more specific, which makes it possible that SEs may be promising therapeutic targets 47,97,106,107 .…”
Section: Future Directionsmentioning
confidence: 99%
“…USP1 can deubiquitinate and stabilize inhibitors of DNA binding proteins (IDs) and subsequently promote the maintenance of mesenchymal stem cells in osteosarcoma 6,15 . USP12 and USP46 are also involved in tumor pathogenesis by deubiquitinating and stabilizing different targets, such as PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1), TP53 and androgen receptor (AR) [24][25][26][27][28] . USP12 deubiquitylates and prevents lysosomal degradation of LAT and Trat1 to maintain the proximal T-cell receptor (TCR) complex for the duration of signaling 29 .…”
mentioning
confidence: 99%